Ping An Voyager Fund, the Hong Kong-based investor in growth stage fintech and healthcare companies, has led the US$35-million Series C funding round in digital dentistry platform PlusDental, which seeks to boost innovation of digital dentistry in Europe.
The funding round, which was also participated by existing investors HV Holtzbrinck Ventures and Lakestar, will be used to further develop PlusDental’s proprietary digital dentistry platform and continue its German and European business expansion.
PlusDental is a Berlin-based health-tech company specializes in digital dentistry and aesthetic orthodontic treatments with clear aligners. It achieves medical treatment results through direct cooperation with local dentists.
The entire therapy process is fully digitalized, from appointment to 3D treatment plan, from follow-up checks to billing. More than 70 dentists in private practice across Germany, Austria, Switzerland, Great Britain, and Spain are already using the Digital Dentistry Platform, PlusDental said.
“We hold the belief that medical responsibility belongs in the hands of specialized and professionally trained registered dentists. Therefore, we are proud to be able to provide the digital infrastructure here and believe that both dentists and patients will benefit from digital dentistry,” said Dr. Peter Baumgart, Co-founder and Managing Director of PlusDental.
The company manufactures its products in its own laboratory in Germany and has since foundation been a committed sponsor of the Deutsche Cleft Kinderhilfe e.V. Since the outbreak of the COVID-19 pandemic, the company has converted its 3D printer fleet to produce medical protective equipment and has already produced more than 7,000 visors, distributed free of charge to medical institutions.
“We are very pleased to lead PlusDental’s Series C financing round. We are highly impressed by the way PlusDental combines its medical excellence with a high degree of digitalization, thus making a valuable contribution to innovation and access to modern dentistry,” according to Dr. Marco Huesch, Chief Medical Officer of Ping An Global Voyager Fund.
Established in 2017 by Ping An, the Ping An Global Voyager Fund typically invests between US$15 million and US$50 million in non-control positions in companies where an affiliation with Ping An is likely to create significant value over time. The Fund has invested approximately US$300 million across Europe, Asia, and North America. – BusinessNewsAsia.com